Home · Open Lab · Lot RGX-26-NAD-674
RGX-26-NAD-674Superseded
NAD+ · 100 MG · Longevity Research · COA NS-2026-05128

Release test results

99.585%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 100.3 mg
Related impurities (total)0.415%
Endotoxin<1.0 EU/mg
HPLC retention time5.06 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundNAD+
Presentation100 MG
Lot numberRGX-26-NAD-674
COA numberNS-2026-05128
Test date07 Sep 2026
Release date10 Sep 2026
Independent labNordicstar Labs
StatusSuperseded

NAD+ — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-NAD-673500 MGSep 8, 202699.570%Superseded
RGX-26-NAD-1026100 MGSep 7, 202699.571%Current
RGX-26-NAD-674 this lot100 MGSep 7, 202699.585%Superseded
RGX-26-NAD-773500 MGSep 5, 202699.768%Superseded
RGX-26-NAD-774100 MGSep 3, 202699.554%Superseded
RGX-26-NAD-1027500 MGSep 2, 202699.609%Current
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →